These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 22991299)
1. Podoplanin expression and its emerging role as a prognostic indicator in systemic tumors besides head and neck malignancies. Kapoor S J Surg Oncol; 2013 Mar; 107(4):446. PubMed ID: 22991299 [No Abstract] [Full Text] [Related]
2. Podoplanin expression in cutaneous head and neck squamous cell carcinoma--prognostic value and clinicopathologic implications. Kreppel M; Krakowezki A; Kreppel B; Drebber U; Wedemeyer I; Mauch C; Zöller JE; Scheer M J Surg Oncol; 2013 Mar; 107(4):376-83. PubMed ID: 22886751 [TBL] [Abstract][Full Text] [Related]
3. Characterisation of Prognosis and Invasion of Cutaneous Squamous Cell Carcinoma by Podoplanin and E-Cadherin Expression. Hesse K; Satzger I; Schacht V; Köther B; Hillen U; Klode J; Schaper K; Gutzmer R Dermatology; 2016; 232(5):558-565. PubMed ID: 27875814 [TBL] [Abstract][Full Text] [Related]
4. Expression of podoplanin in primary and metastatic poorly differentiated and undifferentiated carcinomas of the head and neck. Friedrich RE; Bartel-Friedrich S; Hagel C Anticancer Res; 2012 May; 32(5):2019-22. PubMed ID: 22593482 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome. de Koning PJ; Bovenschen N; Leusink FK; Broekhuizen R; Quadir R; van Gemert JT; Hordijk GJ; Chang WS; van der Tweel I; Tilanus MG; Kummer JA Int J Cancer; 2009 Oct; 125(7):1542-50. PubMed ID: 19569240 [TBL] [Abstract][Full Text] [Related]
6. Prognostic markers in cancers of the head and neck region. Kearsley JH; Thomas S Anticancer Drugs; 1993 Aug; 4(4):419-29. PubMed ID: 8400343 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of expression of p53 protein and Ki-67 antigen in well-differentiated squamous cell carcinoma of the skin. Shimizu T; Murakami T; Oga A; Furumoto H; Nakano J; Muto M J Dermatol; 1999 Dec; 26(12):837-40. PubMed ID: 10659509 [No Abstract] [Full Text] [Related]
8. Identification of circulating tumor cells: a prognostic marker in squamous cell carcinoma of the head and neck? Jatana KR; Lang JC; Chalmers JJ Future Oncol; 2011 Apr; 7(4):481-4. PubMed ID: 21463135 [No Abstract] [Full Text] [Related]
9. Exploration of metastasis-related proteins as biomarkers and therapeutic targets in the treatment of head and neck cancer. Chen ZG Curr Cancer Drug Targets; 2007 Nov; 7(7):613-22. PubMed ID: 18045066 [TBL] [Abstract][Full Text] [Related]
11. Role of podoplanin expression in squamous cell carcinoma of upper aerodigestive tract. Chuang WY; Chang YS; Yeh CJ; Wu YC; Hsueh C Histol Histopathol; 2013 Mar; 28(3):293-9. PubMed ID: 23348382 [TBL] [Abstract][Full Text] [Related]
12. The expression of podoplanin is associated with poor outcome in cutaneous squamous cell carcinoma. Cañueto J; Cardeñoso-Álvarez E; Cosano-Quero A; Santos-Briz Á; Fernández-López E; Pérez-Losada J; Román-Curto C J Cutan Pathol; 2017 Feb; 44(2):144-151. PubMed ID: 27859466 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma. Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871 [TBL] [Abstract][Full Text] [Related]
14. Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas. Hanken H; Gaudin R; Gröbe A; Fraederich M; Eichhorn W; Smeets R; Simon R; Sauter G; Grupp K; Izbicki JR; Sehner S; Heiland M; Blessmann M J Oral Pathol Med; 2014 Apr; 43(4):304-8. PubMed ID: 24645976 [TBL] [Abstract][Full Text] [Related]
15. Cutaneous Adenosquamous Carcinoma of the Scalp With Intestinal Phenotype. Alomran H; Cruel T; Harrou O; Kanitakis J; Balme B Am J Dermatopathol; 2020 Sep; 42(9):e128-e130. PubMed ID: 32379088 [TBL] [Abstract][Full Text] [Related]
16. [Epidermal growth factor (EGF) receptors in squamous cell carcinoma of the head and neck region]. Lörz M; Bettinger R; Meyer-Breiting E Laryngorhinootologie; 1991 Aug; 70(8):438-40. PubMed ID: 1910383 [TBL] [Abstract][Full Text] [Related]
17. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection. Sweeny L; Zimmerman T; Carroll WR; Schmalbach CE; Day KE; Rosenthal EL Otolaryngol Head Neck Surg; 2014 Apr; 150(4):610-7. PubMed ID: 24474713 [TBL] [Abstract][Full Text] [Related]
18. Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival. de Vicente JC; Santamarta TR; Rodrigo JP; García-Pedrero JM; Allonca E; Blanco-Lorenzo V Virchows Arch; 2015 May; 466(5):549-58. PubMed ID: 25726183 [TBL] [Abstract][Full Text] [Related]
19. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma. Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509 [TBL] [Abstract][Full Text] [Related]
20. Spindle cell squamous cell carcinoma showing continuous mesenchymal dedifferentiation in a single tumor. Seike M; Ikeda M; Nakajima H; Kodama H J Dermatol; 2005 Oct; 32(10):813-6. PubMed ID: 16361733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]